MENU
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Empowering Life Sciences for Blooming Life
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Blog
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. Breast Cancer

Breast Cancer– tag –

  • Science News

    How Respiratory Viral Infections May Alter Metastatic Risk in Breast Cancer: Latest Evidence and Practical Guidance

    Even after successful primary treatment, disseminated cancer cells (DCCs) can persist in a dormant state for years and later “awaken,” leading to overt metastasis. Recent studies suggest that respiratory viral infections—such as influenz...
    2025-09-19
  • Oncology Drug

    Catchup News: HER2 ADC Special Report Part 2|IP Strategies, Global Competition, and the Road Ahead

    In Part 1 of our feature, we explored Enhertu’s groundbreaking pharmacological profile and its role in launching the second ADC boom. In this concluding part, we shift focus to intellectual property strategies, patent lifespans, and the ...
    2025-09-10
  • Oncology Drug

    Catchup News: HER2 ADC Special Report Part 1|The Rise of Enhertu and Pharmacological Differentiation Driving the Second ADC Boom

    Antibody-drug conjugates (ADCs) have emerged as one of the most exciting modalities in oncology. Among them, HER2-targeted ADCs have undergone a dramatic transformation with the arrival of Daiichi Sankyo and AstraZeneca’s Enhertu, sparki...
    2025-09-08
1
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English